Raf, AMRN management will do nothing! Now a motivated BP such as Pfizer could probably acquire AMRN and get the US government to pay for it..generics be damned!
I don’t expect management to change course and start telling the world about the cardiovascular benefits of their flagship drug. I see commercials for diabetes and other drugs advertising CVD benefits while Amarin sits silent about theirs. I get that they aren’t spending on TV adds but they could tweet the benefits like you just did. It makes no sense to me.
Market Data 
Markets 
AI
